OCDX News and Press, Ortho Clinical Diagnostics plc From 11/07/21

Ortho Clinical Diagnostics Holdings plc (OCDX) Q3 2021 Earnings Conference Call November 3, 2021 17:00 ET Company Participants Bryan Brokmeier - Vice President of Investor Relations Chris Smith - Chairman & Chief Executive Officer Joe Busky - Chief Financial Officer Mike Iskra - Executive...

Image source: The Motley Fool. Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) Q3 2021 Earnings Call Nov 03, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Ortho Clinical Diagnostics Holdings plc (OCDX) Q3 2...

Ortho Clinical Diagnostics (NASDAQ:OCDX): Q3 Non-GAAP EPS of $0.21 beats by $0.07; GAAP EPS of $0.06 beats by $0.07. Revenue of $522.5M (+15.8% Y/Y) beats by $40.79M. Press Release For further details see: Ortho Clinical Diagnostics EPS beats by $0.07, beats on revenue

Strong Revenue Growth Drives Financial Results Company Raises Fiscal 2021 Guidance Across all Key Metrics RARITAN, N.J., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company”), one of the world's large...

RARITAN, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it will report results for its third quarter 2021 ended October 3, 2021, after the market clos...

Ortho Customers Rank Company No. 1 in Service and Support for Sixth Consecutive Year PR Newswire Company receives top customer rating across six categories in the 2021 IMV ServiceTrak™ Awards RARITAN, N.J. , Sept. 27, 2021 /PRNewswire/ -- Ortho C...

Ortho Clinical Diagnostics Announces Launch of New ISXM Capabilities PR Newswire New Menu Capability Now Available on VISION and VISION MAX Analyzers Increases Confidence in Blood Transfusion-Related Test Results RARITAN, N.J. , Sept. 27, 2021 /PRNewswire...

The following slide deck was published by Ortho Clinical Diagnostics Holdings plc in conjunction with this event. For further details see: Ortho Clinical Diagnostics Holdings (OCDX) Presents At H. C. Wainwright 23rd Annual Global Investment Conference - Slideshow

RARITAN, N.J., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company”), one of the world’s largest pure-play in vitro diagnostics companies, today announced the closing (the “Closing”) of the previously ann...

RARITAN, N.J., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company”), one of the world’s largest pure-play in vitro diagnostics companies, today announced the pricing of the previously announced underwritten secondary ...